Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amos Pines

Showing results (91-100 of 103) with videos related to

Pageof 11
Sort By:
Maturitas|June 30, 2004
Climacteric medicine: European Menopause and Andropause Society (EMAS) statements on postmenopausal hormonal therapySven O Skouby, David Barlow, Göran Samsioe, et al.
American Journal of Obstetrics and Gynecology|April 23, 2002
Neither long-term treatment with raloxifene nor hormone replacement therapy modulate cardiac function in healthy postmenopausal women: two randomized, placebo-controlled, 2-year studiesTatjana E Vogelvang, Velja Mijatovic, Otto Kamp, et al.
Menopause (New York, N.Y.)|September 6, 2017
Menopausal hormone therapy for primary prevention: why the USPSTF is wrongRobert D Langer, James A Simon, Amos Pines, et al.
Maturitas|May 11, 2005
Climacteric medicine: European Menopause and Andropause Society (EMAS) 2004/2005 position statements on peri- and postmenopausal hormone replacement therapySven O Skouby, Farook Al-Azzawi, David Barlow, et al.
Maturitas|April 26, 2021
Topical estrogens and non-hormonal preparations for postmenopausal vulvovaginal atrophy: An EMAS clinical guideAngelica Lindén Hirschberg, Johannes Bitzer, Antonio Cano, et al.
Journal of the National Cancer Institute|December 24, 2013
Re: Estrogen plus progestin and breast cancer incidence and mortality in the women's health initiative observational studySamuel Shapiro, Tobie J deVilliers, Amos Pines, et al.
Maturitas|March 27, 2020
Menopause symptom management in women with dyslipidemias: An EMAS clinical guidePanagiotis Anagnostis, Johannes Bitzer, Antonio Cano, et al.
Maturitas|July 20, 2020
The Mediterranean diet and menopausal health: An EMAS position statementAntonio Cano, Skye Marshall, Irene Zolfaroli, et al.
Maturitas|October 3, 2020
Management of urinary incontinence in postmenopausal women: An EMAS clinical guideEleonora Russo, Marta Caretto, Andrea Giannini, et al.
Maturitas|November 20, 2019
Management of depressive symptoms in peri- and postmenopausal women: EMAS position statementPetra Stute, Areti Spyropoulou, Vasilios Karageorgiou, et al.
Pageof 11

Showing results (91-100 of 103) with videos related to

Sort By:
Pageof 11
Maturitas|June 30, 2004
Climacteric medicine: European Menopause and Andropause Society (EMAS) statements on postmenopausal hormonal therapySven O Skouby, David Barlow, Göran Samsioe, et al.
American Journal of Obstetrics and Gynecology|April 23, 2002
Neither long-term treatment with raloxifene nor hormone replacement therapy modulate cardiac function in healthy postmenopausal women: two randomized, placebo-controlled, 2-year studiesTatjana E Vogelvang, Velja Mijatovic, Otto Kamp, et al.
Menopause (New York, N.Y.)|September 6, 2017
Menopausal hormone therapy for primary prevention: why the USPSTF is wrongRobert D Langer, James A Simon, Amos Pines, et al.
Maturitas|May 11, 2005
Climacteric medicine: European Menopause and Andropause Society (EMAS) 2004/2005 position statements on peri- and postmenopausal hormone replacement therapySven O Skouby, Farook Al-Azzawi, David Barlow, et al.
Maturitas|April 26, 2021
Topical estrogens and non-hormonal preparations for postmenopausal vulvovaginal atrophy: An EMAS clinical guideAngelica Lindén Hirschberg, Johannes Bitzer, Antonio Cano, et al.
Journal of the National Cancer Institute|December 24, 2013
Re: Estrogen plus progestin and breast cancer incidence and mortality in the women's health initiative observational studySamuel Shapiro, Tobie J deVilliers, Amos Pines, et al.
Maturitas|March 27, 2020
Menopause symptom management in women with dyslipidemias: An EMAS clinical guidePanagiotis Anagnostis, Johannes Bitzer, Antonio Cano, et al.
Maturitas|July 20, 2020
The Mediterranean diet and menopausal health: An EMAS position statementAntonio Cano, Skye Marshall, Irene Zolfaroli, et al.
Maturitas|October 3, 2020
Management of urinary incontinence in postmenopausal women: An EMAS clinical guideEleonora Russo, Marta Caretto, Andrea Giannini, et al.
Maturitas|November 20, 2019
Management of depressive symptoms in peri- and postmenopausal women: EMAS position statementPetra Stute, Areti Spyropoulou, Vasilios Karageorgiou, et al.
Pageof 11